Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Rx Fraud Cases: Beat Goes On As Whistleblowers Pursue Lesser Allegations

Related Content

Making A Federal Case Of Marketing Abuses: FDA Trains OCI Staff On Developing Cases Worth Prosecuting

Apr 11 2011

No End In Sight: Pharma Companies Continue To Face Government Probes

Aug 15 2011

GSK’s $750 Mil. DoJ Settlement: When GMP Violations Equal Healthcare Fraud

Nov 01 2010

Related Companies

GSK plc

Ranbaxy Laboratories Limited

Pfizer Inc.

Additional Topics

United States Regulation Legal Issues BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window